4
Changes in Ownership
Kymera Therapeutics, Inc. Filed Acc 0001415889-24-007890
Director sold 353,357 shares at an average $42.20 ($14,912,376)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Booth Bruce · Director
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-11 | Sale : show line 1 in the form 10b5-1 | −37,180 | $42.77 | $1,590,189 | 4,930,934 | I |
| 2024-03-11 | Sale : show line 2 in the form 10b5-1 | −5,122 | $43.42 | $222,397 | 4,925,812 | I |
| 2024-03-11 | Sale : show line 3 in the form 10b5-1 | −7,837 | $42.77 | $335,188 | 882,311 | I |
| 2024-03-11 | Sale : show line 4 in the form 10b5-1 | −1,045 | $43.42 | $45,374 | 881,266 | I |
| 2024-03-12 | Sale : show line 5 in the form 10b5-1 | −126,066 | $41.94 | $5,287,208 | 4,799,746 | I |
| 2024-03-12 | Sale : show line 6 in the form 10b5-1 | −8,581 | $42.52 | $364,864 | 4,791,165 | I |
| 2024-03-12 | Sale : show line 7 in the form 10b5-1 | −26,452 | $41.94 | $1,109,397 | 854,814 | I |
| 2024-03-12 | Sale : show line 8 in the form 10b5-1 | −1,819 | $42.52 | $77,344 | 852,995 | I |
| Open-market sales · 353,357 sh · avg $42.20 · $14,912,376 | ||||||
Loading xslF345X05/form4-03132024_110328.xml…